Skip to content

Clinical trials

Phase 3 Diabetes Mellitus, Type 2 trials in Peru

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 3 Country / region: Peru Clear all

56 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20045
20051
20069
20072
20088
200914
20106
20112
20122
20132
20141
20151
20171
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed46
Terminated10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda13
Boehringer Ingelheim6
GlaxoSmithKline6
AstraZeneca5
Daiichi Sankyo5
Hoffmann-La Roche5
Sanofi5
Phenomix4
Bristol-Myers Squibb2
Novartis Pharmaceuticals2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 256
Diabetes Mellitus22
Glucose Metabolism Disorders9
Dyslipidemias7
Hyperglycemia3
Cardiovascular Diseases2
Glucose Intolerance2
Metabolic Diseases2
Acute Coronary Syndrome1
Coronary Artery Disease1

Trials

Showing 1 to 25 of 56. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.